Pharmaceutical Technology

MARCH 8, 2023

The new technologies will also overcome the manufacturing bottlenecks in delivering advanced engineered cell products. Its focus areas include human systems, precision diagnostics, data sciences, next-generation biomanufacturing, and genomic medicines. Topic sponsors are not involved in the creation of editorial content.

Communication 97

Communication FDA 97

ISPE

FEBRUARY 7, 2023

The two-day conference on 31 January–1 February featured a range of sessions on topics including biomanufacturing, cell and gene therapy, digital transformation and Pharma 4.0™, Hartman noted the importance of attendees’ work in bringing pharmaceuticals to patients. ™, emerging technologies, and facility design and construction.

Vaccines 88

Vaccines Dosage Hospitals 88

Pharmaceutical Technology

AUGUST 17, 2022

These capabilities comprise cell and exosome genetic engineering for expressing therapeutic targets. In order to offer complete process development, quality control and regulatory services, cGMP manufacturing for pre-clinical and Phase I/II clinical trials, AGC will use its worldwide network.

Vaccines 52

Vaccines 52

ISPE

NOVEMBER 1, 2022

2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients. 2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients. Quality and Stability. He presented on “Quality: A Key Ingredient for Stable Pharmaceutical Supply Chains.”. iSpeak Blog.

FDA 98

FDA Insurance Chemotherapy Documentation 98

ISPE

APRIL 19, 2023

Who oversees the different activities such as construction, commissioning, qualification and validation, equipment manufacturing, IT systems, and other technical aspects of the project? What about the engineers? Perform an Impact Systems Analysis. These can include: Who manages the budget? The analysts? The suppliers?

Documentation 52

Documentation Communication 52

ISPE

MARCH 28, 2023

With multiple geopolitical and pandemic related challenges in recent years, having a robust supply chain has increasingly become a strategic advantage for the pharmaceutical industry. The pharmaceutical supply chain runs through the entire process of new drugs from innovation to clinical to approval.

Adverse Reactions 52

Adverse Reactions Packaging Communication Labelling 52

ISPE

MARCH 28, 2023

2022 ISPE China Pharmaceutical Supply Chain Summit Trudy Patterson Tue, 03/28/2023 - 09:24 iSpeak Blog iSpeak 2022 ISPE China Pharmaceutical Supply Chain Summit 28 March 2023 On 17 December 2022, more than 100 people from all over the world gathered online for the 2022 ISPE China Pharmaceutical Supply Chain Summit.

Adverse Reactions 52

Adverse Reactions Packaging Communication Labelling 52

ISPE

NOVEMBER 2, 2022

Executive Director, Computer Systems Quality & Data Integrity. Strategic plan refresh for 2023–2025 involved an adaptation from the existing strategic plan, with the Society taking a “very confident position: Shaping the Future of Pharma and bringing quality medicines to patients worldwide.”. Project Manager/ Engineer.

Documentation 52

Documentation Compounding Communication FDA 52

ISPE

MARCH 23, 2023

As the momentum grows in the rollout of various digital tools to aid verification and validation in the pharmaceutical space there are many questions in relation to the correct application of the True Copy process to digital evidence within protocols in a paperless validation system.

Documentation 98

Documentation FDA 98

ISPE

OCTOBER 28, 2022

Given terminology differences across jurisdictions, these products are sometimes more broadly referred to as ‘combined use systems.’. Pharmaceutical Engineering® recently spoke with Neadle about the Communities of Practice and issues related to the importance of combination products in the industry. Neadle, FAAO, FBCLA.

FDA 52

FDA 52

ISPE

JANUARY 11, 2023

Life-Cycle Approach to Cleaning Topical Drug Products Trudy Patterson Wed, 01/11/2023 - 10:17 Technical January / February 2023 Life-Cycle Approach to Cleaning Topical Drug Products Dijana Hadziselimovic Kamini I. However, some of the products manufactured in a topical drug facility can be difficult to clean. Lopolito Steven M.

Method Validation 52

Method Validation Documentation Packaging Compounding 52

Viseven

MAY 15, 2023

Pharmaceutical detailing is the most time-tested marketing format in the medical content world. Old-timer sales reps should remember how pharmaceutical companies reckoned face-to-face (F2F) visits with doctors as the most effective approach to achieving their sales targets. What is Pharmaceutical Detailing?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Patient Care 52

ISPE

OCTOBER 28, 2022

This artificial intelligence (AI) retrofit project was a unique approach to implementing AI technology in a pharmaceutical environment within three months. Manual inspection and automated systems can achieve a similar level of sensitivity, but there are specific strengths and weaknesses for both methods. Christian Stirnimann.

Labelling 52

Labelling Pharmaceutical Companies Pharmaceutical Companies Packaging 52

Viseven

JANUARY 13, 2023

So what do exactly HEOR experts do for the pharmaceutical companies and what HEOR-collected data is used for? There is a number of specific tasks that HEORs fulfill or contribute to that help to increase the quality of the products and, hence, the quality of treatment. What is HEOR Data?

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Dosage Documentation 40

ISPE

FEBRUARY 21, 2023

ISPE’s Women in Pharma initiative is committed to diversifying the pharmaceutical industry, paving the way for a more inclusive work culture. Women in Pharma aspires to create a pharmaceutical industry that is equitable, inclusive, free of biases and stereotypes, where diversity of thought thrives. Women in Pharma

Insurance 52

Insurance 52

Viseven

OCTOBER 26, 2022

The pharmaceutical industry still faces significant challenges and is looking for innovative solutions. Below are five of the most significant pharmaceutical industry problems. . Therefore, to reduce the challenges of their pharmaceutical supply chain, they changed their strategy and made the most use of the resources available.

Hospitals 52

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

OCTOBER 2, 2020

New research shows that the COVID-19 pandemic is encouraging people to take their health into their own hands, and experts say this trend towards self-care could be a significant boon for healthcare systems – one the pharma industry should be encouraging. Self-care will even up resources and give a better shape to our healthcare system.”.

Communication 111

Communication 111

ISPE

JULY 19, 2023

has taken on significantly increasing momentum in the pharmaceutical industry. ™ opens new opportunities for quality, safety, productivity, and patient benefit. Drug shortages are the consequence, seen in all regions of the world and possible for practically all pharmaceuticals. The concept of Industry 4.0

Documentation 98

Documentation FDA Labelling Communication 98

ISPE

JULY 10, 2023

However, their arrival requires reconsiderations on risks, quality assurance, and validation from a GxP perspective. We will examine this question from quality, risk, and efficiency perspectives and discuss how such tools can shift the way we think about validation and quality assurance.

Labelling 52

Labelling Documentation Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

OCTOBER 27, 2022

Emerging digital health technologies (DHTs) may improve the quality of life for patients with chronic and debilitating diseases and provide novel health care solutions for patients with unmet medical needs. An EHR is a subset of health information technology and consists of an individual patient record contained within an EHR system.

Health and Personal Care Stores 52

Health and Personal Care Stores FDA Communication Clinic Management 52

ISPE

OCTOBER 27, 2022

Emerging digital health technologies (DHTs) may improve the quality of life for patients with chronic and debilitating diseases and provide novel health care solutions for patients with unmet medical needs. An EHR is a subset of health information technology and consists of an individual patient record contained within an EHR system.

Health and Personal Care Stores 52

Health and Personal Care Stores FDA HIPAA Communication 52

European Pharmaceutical Review

OCTOBER 2, 2023

At the Heart of Pharma Conference agenda highlights CPHI Barcelona 2023 will feature an extensive conference agenda covering a wide range of topics, including next-gen biomanufacturing, partnering for success, formulating the future, future therapies, manufacturing 4.0, Patient Centric Development , and Quality Management Fundamentals.

Packaging 102

Packaging 102

ISPE

NOVEMBER 10, 2022

Cell therapy involves modifying the human immune system by introducing cancer-specific T cells or regenerating damaged tissue by transplanting stem cells. Pharmaceutical Engineering® recently spoke with Kawamata about his work. He was appointed as a Senior Researcher at the Institute of Biomedical Research and Innovation at the?FBRI

Documentation 98

Documentation Compounding Hospitals Immunization 98

PharmaShots

MARCH 6, 2023

Traditionally patients were viewed by pharmaceutical companies as simply users of our products, nowadays they are considered partners working towards a collective goal. Clinical trials are a key topic for these interactions. As a result of this progression, our industry developed the notion of patient-centricity.

Immunization 40

Immunization Pharmaceutical Companies Pharmaceutical Companies Hospitals 40

ISPE

OCTOBER 26, 2022

The session, which will be moderated by Michael O’Brien, PhD, President & CEO of NGT BioPharma Consultants, will address potential financial, technical, quality, and regulatory challenges while highlighting known and anticipated opportunities associated with the transportability of autonomous manufacturing environments. Principal Engineer.

FDA 52

FDA 52

ISPE

SEPTEMBER 11, 2023

Cauchon, PhD 1 September 2023 The biopharmaceutical industry must develop and implement innovative ways of working to be effective and efficient in the current healthcare ecosystem, in which high-quality medicines, adaptability, and assurance of supply are of critical importance.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Organic compounds are arguably the foundation of the pharmaceutical industry.

Compounding 82

Compounding Pharmaceutical Companies Pharmaceutical Companies Packaging 82

ISPE

MARCH 1, 2023

Initiatives such as Process Analytical Technology (PAT), and Quality by Design, challenge life science companies to achieve true process control, emphasizing the importance of real-time measurement. Once submitted, you will receive a link via the email you provided to download the white paper.

Communication 52

Communication 52

Roots Analysis

SEPTEMBER 22, 2023

These significant benefits offered by wearable injectors, coupled with their rising demand in the pharmaceutical industry and healthcare sector, worldwide is likely to drive market growth during in the coming years. They offer a bridge between traditional injections and continuous infusion systems.

Hospitals 40

Hospitals Dosage Chemotherapy Insurance 40

PharmaShots

FEBRUARY 27, 2023

After the auspicious start, the chairman of global PHT – Dr. Jagadeesh Babu Rangisetty (CEO – Biophore India Pharmaceuticals, India), and the convenor Dr. Upendra Nagaich (National Secretary – SPER, India) gave the conference opening remarks. So, to summarise I hope that the future will be organized to manage such crisis.”

Packaging 40

Packaging Hospitals FDA Pharmaceutical Companies 40

ISPE

SEPTEMBER 12, 2022

Director, Office of Pharmaceutical Quality Operations. Deputy Director, Office of Manufacturing Quality. Director External Engagement and Supplier Quality. I'd like to concur that data integrity issues and poor data governance can be found in any sector of pharmaceutical manufacturing. Panelists: Alonza Cruse.

FDA 52

FDA Documentation Communication 52

ISPE

MARCH 6, 2023

Sustainability Definitions for the Pharmaceutical Industry Trudy Patterson Mon, 03/06/2023 - 10:26 Features March / April 2023 Sustainability Definitions for the Pharmaceutical Industry William G. Green Manufacturing for the Pharmaceutical Industry.” while meeting patient needs as a primary goal. 1 European Commission.

Communication 52

Communication Patient Care 52

ISPE

JULY 7, 2023

4 , 5 Other challenges reflect the cautious nature of pharmaceutical manufacturing, like risk aversion and regulatory considerations. Chemical Engineering Science (2021): 231. Annual Review of Chemical and Biomolecular Engineering 13 (2022): 141–65. 1 , 2 , 3 There are also barriers to the adoption of BCM. Bi, and A.

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

MAY 11, 2023

The key to data integrity compliance is a well-functioning data governance system 1 , 2 in which the data flow path for all business processes and equipment—such as in manufacturing, laboratory, and clinical studies—is fully understood and documented by a detailed process data flow map. Published June 2008.

Packaging 52

Packaging Documentation Communication Data Entry 52

ISPE

OCTOBER 28, 2022

The conference focused on the ongoing development and growth in these technologies, and featured speakers on a broad range of topics, including advanced manufacturing and how lessons learned from COVID-19 vaccine development can apply to biologics development. Building a New Platform. Highlights of the discussion follow. Collaboration.

Vaccines 52

Vaccines FDA Immunization 52

ISPE

AUGUST 30, 2022

The pharmaceutical manufacturing supply chain starts with the raw materials, which are needed to ensure drug availability for patients. Finally, the DP is packaged in a suitable container to ensure continued quality. With ever-increasing supply chain challenges, raw material shortages have become a point of discussion.

Documentation 52

Documentation FDA Packaging Communication 52

ISPE

MARCH 7, 2023

Melton, PhD 1 March 2023 The imperative for global action to tackle climate change is clear and the pharmaceutical industry has a key role to play. 1 , 2 The effect to the pharmaceutical industry spans its end-to-end activities, including the residual impact of used and unused medicines on the environment.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52